TipRanks
Advertisement
Advertisement

IT:1GILD Stock Latest News

Gilead price target raised to $126 from $123 at RBC Capital
The FlyGilead price target raised to $126 from $123 at RBC Capital
3d ago
GILD
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
PremiumTipRanks Newswire
Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)
3d ago
LLY
AMGN
Early notable gainers among liquid option names on October 7th
PremiumThe Fly
Early notable gainers among liquid option names on October 7th
3d ago
KR
MPC
Gilead price target raised to $158 from $150 at Truist
PremiumThe Fly
Gilead price target raised to $158 from $150 at Truist
4d ago
GILD
Gilead price target lowered to $163 from $165 at Morgan Stanley
PremiumThe Fly
Gilead price target lowered to $163 from $165 at Morgan Stanley
4d ago
GILD
Gilead price target raised to $170 from $160 at JPMorgan
PremiumThe FlyGilead price target raised to $170 from $160 at JPMorgan
4d ago
GILD
Cognizant announces five-year extension of its work with Gilead Sciences
Premium
The Fly
Cognizant announces five-year extension of its work with Gilead Sciences
5d ago
CTSH
GILD
Nurix Therapeutics announces second research term extension with Gilead
Premium
The Fly
Nurix Therapeutics announces second research term extension with Gilead
6d ago
GILD
NRIX
Gilead put volume heavy and directionally bearish
PremiumThe Fly
Gilead put volume heavy and directionally bearish
10d ago
GILD
Michael Yee Reiterates Buy on Gilead, Highlighting Yeztugo-Driven HIV Growth and Maintaining Unchanged $175 Price Target
PremiumRatings
Michael Yee Reiterates Buy on Gilead, Highlighting Yeztugo-Driven HIV Growth and Maintaining Unchanged $175 Price Target
16d ago
GILD
Gilead announces expanded scope of licensing agreements for lenacapavir
PremiumThe Fly
Gilead announces expanded scope of licensing agreements for lenacapavir
25d ago
GILD
Gilead announces agreement with PAHO for lenacapavir access
PremiumThe Fly
Gilead announces agreement with PAHO for lenacapavir access
25d ago
GILD
Gilead price target raised to $175 from $155 at HSBC
PremiumThe FlyGilead price target raised to $175 from $155 at HSBC
1M ago
GILD
Assembly Biosciences exercises profit share option with Gilead for HSV program
Premium
The Fly
Assembly Biosciences exercises profit share option with Gilead for HSV program
1M ago
ASMB
GILD
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
Premium
The Fly
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
1M ago
GILD
Lakefront Biotherapeutics granted orphan drug designation for gamgertamig
PremiumThe Fly
Lakefront Biotherapeutics granted orphan drug designation for gamgertamig
2M ago
GILD
LKFT
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
PremiumThe Fly
Gilead says EC grants marketing authorization for Trodelvy/Keytruda combination
2M ago
MRK
GILD
MacroGenics receives $10M milestone after Gilead exercises license option
PremiumThe Fly
MacroGenics receives $10M milestone after Gilead exercises license option
2M ago
GILD
MGNX
Gilead Sciences Earnings Call Highlights Strong Core Growth
PremiumCompany Announcements
Gilead Sciences Earnings Call Highlights Strong Core Growth
2M ago
GILD
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
PremiumRatingsGilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
2M ago
GILD
Gilead files automatic mixed securities shelf
Premium
The Fly
Gilead files automatic mixed securities shelf
2M ago
GILD
Gilead price target lowered to $150 from $156 at Truist
Premium
The Fly
Gilead price target lowered to $150 from $156 at Truist
2M ago
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >